North America Acne Medication Market Forecast to 2030
North America Acne Medication Market Forecast to 2030 – Regional Analysis – by Therapeutic Class (Retinoids, Benzoyl Peroxide, Antibiotics, Salicylic Acid, and Others), Formulation (Topical Medication and Oral Medication), Type (Prescription Medicine and Over-the-Counter Medicine), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Pharmacies and Drug Stores, Retail Stores, and E-Commerce)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Upsurge in Need for Organic and Natural Treatments Fuels North America Acne Medication Market
As people are becoming more conscious of the potentially harmful effects of synthetic ingredients and chemicals used in traditional skincare products, the demand for natural and organic alternatives that are deemed to be safer, gentler, and more environmentally friendly is on the rise across the world. Consumers are increasingly seeking products free from harsh chemicals, artificial fragrances, and potentially irritating substances, opting for formulations that harness the power of plant-based ingredients, botanical extracts, essential oils, and other natural compounds known for their skincare benefits. In response to this trend, many skincare brands and manufacturers are developing a wide range of natural and organic acne treatment products that cater to the needs of health-conscious consumers. These products often feature ingredients such as tea tree oil, witch hazel, aloe vera, green tea extract, and salicylic acid derived from natural sources, offering a more holistic and sustainable approach to treating acne without compromising efficacy. In July 2022, MÁDARA, an organic skincare business, introduced two new and natural everyday skincare products—a microbiome-balancing moisturizer and a non-drying face cleanser. The company claims that these products were developed by blending science and nature, and were specifically formulated to offer gentle treatment for people of different complexions, who are prone to acne. Both products are made with natural, organic, and vegan ingredients—Northern Juniper Stem Cells, fermented polysaccharides, and lichen and Maté tea extracts—which deal specifically with imperfections, keeping the skin unharmed. Adults and teenagers can both utilize this product. Thus, the increasing preference for natural and organic acne treatment options is expected to continue shaping the future of the North America acne medication market in the coming years.
The shift toward natural and organic acne treatment options is also driven by the increasing stringency of regulatory scrutiny and complications associated with industry standards. Regulatory agencies emphasize ingredient transparency, safety, and sustainability, prompting companies to reformulate their products to meet evolving consumer preferences for cleaner and greener skincare solutions. Thus, as more consumers prioritize natural ingredients and eco-friendly formulations in their skincare routines, the North America acne medication market is expected to experience new growth trends in the coming years.
North America Acne Medication Market Overview
The acne medication market in North America is segmented into the US, Canada, and Mexico. The US held the largest North American acne medication market share in 2022. Acne is a skin condition brought on by debris, oil, sebum, and dead skin cells clogging hair follicles. According to the American Academy of Dermatology, acne is the most prevalent illness in the US, up to 50 million Americans suffer from acne each year, making it the most common skin ailment in the country. The acne medication market in this country is projected to expand due to the increased incidence of acne in Americans and the subsequent launch of various innovative acne medications.
North America Acne Medication Market Revenue and Forecast to 2030 (US$ Million)
North America Acne Medication Market Segmentation
The North America acne medication market is segmented based on therapeutic class, formulation, type, acne type, and distribution channel, and country.
Based on therapeutic class, the North America acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.
In terms of formulation, the North America acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.
By type, the North America acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.
Based on acne type, the North America acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.
In terms of distribution channel, the North America acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.
Based on country, the North America acne medication market is categorized into US, Canada, and Mexico. The US dominated the North America acne medication market in 2022.
Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Centro Internacional de Cosmiatria SA de CV, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, Somar Sapi De CV, and Italmex SA are some of the leading companies operating in the North America acne medication market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Geographical coverage: | |
| Year of Publication: |
According to the Research Team’ research, the North America acne medication market was valued at US$ 3,362.50 million in 2022 and is expected to reach US$ 4,794.01 million by 2030, registering a CAGR of 4.6% from 2023 to 2030. Increasing prevalence of severe acne and launch of novel drugs are among the critical factors attributed to the North America acne medication market expansion.
Severe acne, often characterized by painful cysts, nodules, and persistent inflammation, presents a considerable challenge that can significantly impact people’s quality of life. As per the 2022 GBD research, acne has a prevalence rate of 9.4%, ranking it eighth among the most common diseases in the world. Acne vulgaris affects over 85% of young individuals from the age group of 12-25. Such a high prevalence has led to an upsurge in the demand for effective acne medications tailored to address moderate to severe forms of the condition. As individuals seek ways to mitigate the physical and emotional burden associated with severe acne, there is a corresponding increase in the demand for advanced and more effective prescription and over-the-counter treatments. This trend prompts pharmaceutical companies to focus on developing innovative formulations, including topical retinoids, oral antibiotics, hormonal therapies, and advanced topical treatments, to address the complex needs of individuals with severe acne. The Journal of Drugs in Dermatology (JDD) estimates that acne treatments incur over US$ 1 billion as direct annual costs to the US economy, with over-the-counter acne drugs accounting for nearly 10% of this cost. JDD also estimates that billions of dollars would be spent on acne treatment in the coming years. Thus, the increasing prevalence of severe acne and an upsurge in associated costs to economies bolster the North America acne medication market growth.
On the contrary, side effects associated with acne medication hampers the growth of North America acne medication market.
Based on therapeutic class, the North America acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held 33.5% share of the North America acne medication market in 2022, amassing US$ 1,125.28 million. It is projected to garner US$ 1,809.24 million by 2030 to expand at 6.2% CAGR during 2023-2030.
In terms of formulation, the North America acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held 68.7% share of the North America acne medication market in 2022, amassing US$ 2,311.17 million. It is estimated to garner US$ 3,414.72 million by 2030 to expand at 5.0% CAGR during 2023-2030.
By type, the North America acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held 65.2% share of North America acne medication market in 2022, amassing US$ 2,191.15 million. It is predicted to garner US$ 3,247.71 million by 2030 to expand at 5.1% CAGR during 2023-2030.
Based on acne type, the North America acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held 54.7% share of the North America acne medication market in 2022, amassing US$ 1,840.10 million. It is projected to garner US$ 2,689.65 million by 2030 to expand at 4.9% CAGR during 2023-2030.
In terms of distribution channel, the North America acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held 49.7% share of the North America acne medication market in 2022, amassing US$ 1,672.44 million. It is estimated to garner US$ 2,512.04 million by 2030 to expand at 5.3% CAGR during 2023-2030.
Based on country, the North America acne medication market is categorized into the US, Canada, and Mexico. The US held 85.6% share of North America acne medication market in 2022, amassing US$ 2,879.64 million. It is projected to garner US$ 4,130.04 million by 2030 to expand at 4.7% CAGR during 2023-2030.
Key players operating in the North America acne medication market are Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Centro Internacional de Cosmiatria SA de CV, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, Somar Sapi De CV, and Italmex SA., among others.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in North America acne medication market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
1. Introduction
1.1 The the Reporting Teams Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Acne Medication Market Landscape
4.1 PEST Analysis
4.2 Pricing Analysis of Topical and Oral Medication
4.3 Patient Population Undergoing Acne Treatment
5. North America Acne Medication Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Severe Acne
5.1.2 Launch of Novel Drugs
5.2 Key Market Restraints
5.2.1 Side Effects Associated with Acne Medication
5.3 Key Market Opportunities
5.3.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
5.4 Future Trends
5.4.1 Upsurge in Need for Organic and Natural Treatments
5.5 Impact of Drivers and Restraints:
6. Acne Medication Market – North America Market Analysis
7. North America Acne Medication Market Analysis – by Therapeutic Class
7.1 Retinoids
7.1.1 Overview
7.1.2 Retinoids: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.2 Benzoyl Peroxide
7.2.1 Overview
7.2.2 Benzoyl Peroxide: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Antibiotics
7.3.1 Overview
7.3.2 Antibiotics: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Salicylic Acid
7.4.1 Overview
7.4.2 Salicylic Acid: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Acne Medication Market Analysis – by Formulation
8.1 Topical Medication
8.1.1 Overview
8.1.2 Topical Medication: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Oral Medication
8.2.1 Overview
8.2.2 Oral Medication: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Acne Medication Market Analysis – by Type
9.1 Prescription Medicine
9.1.1 Overview
9.1.2 Prescription Medicine: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Over-the-Counter Medicine
9.2.1 Overview
9.2.2 Over-the-Counter Medicine: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Acne Medication Market Analysis – by Acne Type
10.1 Non-Inflammatory Acne
10.1.1 Overview
10.1.2 Non-Inflammatory Acne: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
10.2 Inflammatory Acne
10.2.1 Overview
10.2.2 Inflammatory Acne: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11. North America Acne Medication Market Analysis – by Distribution Channel
11.1 Pharmacies and Drug Stores
11.1.1 Overview
11.1.2 Pharmacies and Drug Stores: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11.2 Retail Stores
11.2.1 Overview
11.2.2 Retail Stores: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
11.3 E-Commerce
11.3.1 Overview
11.3.2 E-Commerce: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12. North America Acne Medication Market – Country Analysis
12.1 North America
12.1.1 North America: Acne Medication Market – Revenue and Forecast Analysis – by Country
12.1.1.1 North America: Acne Medication Market – Revenue and Forecast Analysis – by Country
12.1.1.2 US
12.1.1.3 US: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.3.1 US: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.3.2 US: Acne Medication Market Breakdown, by Formulation
12.1.1.3.3 US: Acne Medication Market Breakdown, by Type
12.1.1.3.4 US: Acne Medication Market Breakdown, by Acne Type
12.1.1.3.5 US: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.4 Canada
12.1.1.5 Canada: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.5.1 Canada: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.5.2 Canada: Acne Medication Market Breakdown, by Formulation
12.1.1.5.3 Canada: Acne Medication Market Breakdown, by Type
12.1.1.5.4 Canada: Acne Medication Market Breakdown, by Acne Type
12.1.1.5.5 Canada: Acne Medication Market Breakdown, by Distribution Channel
12.1.1.6 Mexico
12.1.1.7 Mexico: Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
12.1.1.7.1 Mexico: Acne Medication Market Breakdown, by Therapeutic Class
12.1.1.7.2 Mexico: Acne Medication Market Breakdown, by Formulation
12.1.1.7.3 Mexico: Acne Medication Market Breakdown, by Type
12.1.1.7.4 Mexico: Acne Medication Market Breakdown, by Acne Type
12.1.1.7.5 Mexico: Acne Medication Market Breakdown, by Distribution Channel
13. Acne Medication Market- Industry Landscape
13.1 Overview
13.2 Growth Strategies in Acne Medication Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
13.5 Product Offered by Farmapiel vs Other Companies Acne Products
14. Company Profiles
14.1 Teva Pharmaceutical Industries Ltd
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Almirall SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Johnson & Johnson
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Bausch Health Companies Inc
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Centro Internacional de Cosmiatria SA de CV
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Galderma SA
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Pfizer Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 GSK Plc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Viatris Inc
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 Somar Sapi De CV
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
14.12 Italmex SA
14.12.1 Key Facts
14.12.2 Business Description
14.12.3 Products and Services
14.12.4 Financial Overview
14.12.5 SWOT Analysis
14.12.6 Key Developments
15. Appendix
15.1 About The the Reporting Teams
15.2 Glossary of Terms
Table 1. North America Acne Medication Market Segmentation
Table 2. Topical Medication
Table 3. Oral Medication
Table 4. Patient Population undergoing Acne Treatment from 2020-2023
Table 5. North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Therapeutic Class
Table 6. North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Formulation
Table 7. North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Type
Table 8. North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Acne Type
Table 9. North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million) – by Distribution Channel
Table 10. North America: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 11. US: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 12. US: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 13. US: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 14. US: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 15. US: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 16. Canada: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 17. Canada: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 18. Canada: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 19. Canada: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 20. Canada: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 21. Mexico: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Therapeutic Class
Table 22. Mexico: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Formulation
Table 23. Mexico: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Type
Table 24. Mexico: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Acne Type
Table 25. Mexico: Acne Medication Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 26. Recent Organic Growth Strategies in Acne Medication Market
Table 27. Recent Inorganic Growth Strategies in the Acne Medication Market
Table 28. Glossary of Terms, Acne Medication Market
Figure 1. North America Acne Medication Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. North America Acne Medication Market – Key Market Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. North America Acne Medication Market Revenue (US$ Million), 2020-2030
Figure 6. North America Acne Medication Market Share (%) – by Therapeutic Class (2022 and 2030)
Figure 7. Retinoids: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Benzoyl Peroxide: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Antibiotics: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Salicylic Acid: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Acne Medication Market Share (%) – by Formulation (2022 and 2030)
Figure 13. Topical Medication: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oral Medication: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. North America Acne Medication Market Share (%) – by Type (2022 and 2030)
Figure 16. Prescription Medicine: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Over-the-Counter Medicine: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Acne Medication Market Share (%) – by Acne Type (2022 and 2030)
Figure 19. Non-Inflammatory Acne: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Inflammatory Acne: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America Acne Medication Market Share (%) – by Distribution Channel (2022 and 2030)
Figure 22. Pharmacies and Drug Stores: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Retail Stores: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. E-Commerce: North America Acne Medication Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America: Acne Medication Market – Country, 2022 (US$ Million)
Figure 26. North America: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. US: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. Canada: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Mexico: Acne Medication Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in Acne Medication Market
The List of Companies – North America Acne Medication Market
1. Teva Pharmaceutical Industries Ltd
2. Almirall SA
3. Johnson & Johnson
4. Sun Pharmaceutical Industries Ltd
5. Bausch Health Companies Inc
6. Centro Internacional de Cosmiatria SA de CV
7. Galderma SA
8. Pfizer Inc
9. GSK Plc
10. Viatris Inc
11. Somar Sapi De CV
12. Italmex SA
You must be logged in to post a review.
Reviews
There are no reviews yet.